2025年全球診斷即服務市場報告

近年來，診斷即服務（DaaS）市場規模呈指數級成長，從2024年的44.5億美元成長到2025年的54億美元，複合年成長率達21.2%。這一成長主要與數位醫療的興起、對疾病早期檢測需求的增加、雲端基礎方案的廣泛應用、不斷上漲的醫療成本促使人們尋求更高效的解決方案，以及對更快、更準確的診斷的需求不斷成長等因素相關。

預計未來幾年，診斷即服務 (DaaS) 市場規模將呈指數級成長，到 2029 年將達到 115 億美元，複合年成長率 (CAGR) 為 20.8%。預測期內的成長與慢性病患病率上升、個性化醫療的擴展、遠端和居家檢測需求的成長、對經濟高效診斷的日益重視以及對數位醫療解決方案的支持性監管措施密切相關。預測期內的關鍵趨勢包括：人工智慧驅動的診斷、雲端基礎的採用、多組學整合體學、遠端和居家檢測、具有數位彙報功能的即時分析、區塊鏈數據安全以及以患者為中心的個人化診斷即服務。

預計未來幾年，慢性病盛行率的上升將推動診斷即服務（DaaS）市場的擴張。慢性病是指需要持續醫療照護的長期健康狀況，其流行往往與缺乏運動的生活方式有關。久坐不動的生活方式，例如長時間坐著和缺乏體能鍛煉，會增加心臟病和糖尿病等疾病的風險。診斷即服務透過支援雲端基礎的檢測和分析，促進長期健康監測，在慢性病管理中發揮關鍵作用。這項服務透過提供及時的資訊、減少頻繁就醫的需求以及改善慢性病患者的就醫途徑，從而提升了患者的護理品質。例如，英國國家醫療服務體系（NHS）在2024年6月報告稱，2023年有3,615,330人被診斷患有非糖尿病性高血糖症（一種以血糖值升高為特徵的疾病），比2022年成長了18%。這一趨勢凸顯了對持續監測日益成長的需求，並正在推動診斷即服務市場的發展。

個人化醫療的日益普及也推動了診斷即服務市場的成長。個人化醫療根據個人的基因組成、生活方式和環境來制定個人化的治療和預防方案。這種方法的興起主要歸功於基因組學的進步，基因組學能夠準確地識別基因變異並制定個人化治療方案。診斷即服務透過提供雲端基礎的診斷工具來增強個人化醫療，這些工具能夠快速、準確地評估患者病情。這些服務簡化了資料收集和分析流程，支援客製化的治療策略，並改善臨床決策。例如，個人化醫療聯盟在2024年2月報告稱，美國食品藥物管理局）在2023年核准了26種新的個人化藥物。個人化醫療的快速普及正在推動診斷即服務市場的成長。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅，以及新冠疫情及其復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 全球診斷即服務：PESTEL 分析（政治、社會、科技、環境、法律因素、促進因素與限制因素）
• 終端用戶產業分析
• 全球診斷即服務市場：成長率分析
• 全球診斷即服務市場表現：規模與成長，2019-2024 年
• 全球診斷即服務市場預測：規模與成長，2024-2029年，2034年
• 全球診斷即服務：潛在市場規模 (TAM)

第6章 市場細分

• 全球診斷即服務市場按組件、效能和預測分類，2019-2024年、2024-2029年、2034年
• 軟體
• 服務
• 平台
• 全球診斷即服務市場依部署模式、效能及預測分類，2019-2024年、2024-2029年、2034年
• 雲端基礎的
• 本地部署
• 混合
• 全球診斷即服務市場按應用、效能和預測分類，2019-2024年、2024-2029年、2034年
• 臨床診斷
• 影像診斷
• 病理
• 基因組學
• 其他用途
• 全球診斷即服務市場（按最終用戶、效能和預測分類），2019-2024 年、2024-2029 年、2034 年
• 醫院和診所
• 診斷實驗室
• 研究所
• 其他最終用戶
• 全球診斷即服務市場：依軟體、類型、效能及預測細分，2019-2024年、2024-2029年、2034年
• 診斷分析軟體
• 臨床決策支援軟體
• 基於人工智慧 (AI) 或機器學習 (ML) 的診斷工具
• 成像和視覺化軟體
• 數據整合和互通性軟體
• 遠端監控和報告軟體
• 全球診斷即服務市場：按服務、類型、效能和預測細分，2019-2024年、2024-2029年、2034年
• 診斷測試服務
• 遠端/虛擬診斷服務
• 雲端基礎的資料儲存和管理
• 諮詢及實施服務
• 培訓和支援服務
• 維護和升級服務
• 全球診斷即服務市場：按平台、類型、效能和預測細分，2019-2024年、2024-2029年、2034年
• 雲端基礎的診斷平台
• 本地診斷平台
• 混合部署平台
• 應用程式介面（API）和整合平台
• 移動或遠距離診斷平台
• 資料交換與協作平台

第7章 區域和國家分析

• 全球診斷即服務市場：依地區、績效及預測分類，2019-2024年、2024-2029年、2034年
• 全球診斷即服務市場：國家/地區、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

• 診斷即服務市場：競爭格局
• 診斷即服務市場：公司概況
  • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • Koninklijke Philips NV Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

• GE Healthcare Technologies Inc.
• Becton Dickinson and Company
• Agilent Technologies Inc.
• Hologic Inc.
• Bio-Rad Laboratories Inc.
• Guardant Health Inc.
• Invitae Corporation
• InHealth Group Limited
• Canon Medical Systems Corporation
• Freenome Holdings Inc.
• BioSerenity SAS
• PathAI Inc.
• Butterfly Network Inc.
• Aidoc Medical Ltd.
• Owkin Inc.

第32章 全球市場競爭基準化分析與儀錶板

第33章 重大併購

第34章 近期市場趨勢

第35章：高潛力市場國家、細分市場與策略

• 2029年診斷即服務市場：提供新機會的國家
• 2029年診斷即服務市場：提供新機會的細分市場
• 2029年診斷即服務市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手策略

第36章附錄

Diagnostics-as-a-service is a cloud-based healthcare approach that offers diagnostic testing, analysis, and reporting via digital platforms, often utilizing artificial intelligence (AI), internet of things (IoT), and remote connectivity. It provides scalable, cost-efficient, and accessible diagnostic solutions without requiring extensive on-site infrastructure. The model supports real-time health monitoring, quicker decision-making, and better patient outcomes by optimizing diagnostic delivery across healthcare environments.

The primary elements of diagnostics-as-a-service are software, services, and hardware. Software includes cloud-based platforms that deliver on-demand diagnostic testing, analysis, and reporting, facilitating scalable, cost-effective, and accessible healthcare diagnostics. It can be implemented through cloud-based, on-premises, or hybrid systems. Applications cover clinical diagnostics, imaging, pathology, genomics, and more, serving hospitals, clinics, diagnostic laboratories, research institutes, and other users.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The diagnostics-as-a-service market research report is one of a series of new reports from The Business Research Company that provides diagnostics-as-a-service market statistics, including the diagnostics-as-a-service industry global market size, regional shares, competitors with the diagnostics-as-a-service market share, detailed diagnostics-as-a-service market segments, market trends, and opportunities, and any further data you may need to thrive in the diagnostics-as-a-service industry. This diagnostics-as-a-service market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The diagnostics-as-a-service market size has grown exponentially in recent years. It will grow from $4.45 billion in 2024 to $5.40 billion in 2025 at a compound annual growth rate (CAGR) of 21.2%. The growth in the historic period can be linked to the rise of digital healthcare, increasing demand for early disease detection, wider adoption of cloud-based solutions, growing healthcare costs driving the need for efficient approaches, and a heightened demand for faster, more accurate diagnostics.

The diagnostics-as-a-service market size is expected to see exponential growth in the next few years. It will grow to $11.50 billion in 2029 at a compound annual growth rate (CAGR) of 20.8%. The growth in the forecast period can be linked to the rising prevalence of chronic diseases, expansion of personalized medicine, growing demand for remote and home-based testing, increased focus on cost-effective diagnostics, and supportive regulatory measures for digital healthcare solutions. Key trends during the forecast period include the use of AI-driven diagnostics, adoption of cloud-based platforms, integrated multi-omics approaches, remote and at-home testing, real-time analytics with digital reporting, blockchain-enabled data security, and patient-centric, personalized diagnostic services.

The rising prevalence of chronic diseases is expected to drive the expansion of the diagnostics-as-a-service market in the coming years. Chronic diseases are long-lasting health conditions that require ongoing medical care, often becoming more prevalent due to inactive lifestyles. Sedentary behavior, such as prolonged sitting and minimal physical activity, increases the likelihood of developing conditions such as heart disease and diabetes. Diagnostics-as-a-service plays a crucial role in managing chronic diseases by enabling cloud-based testing and analysis, which facilitates the monitoring of long-term health conditions. This service enhances patient care by providing timely insights, reducing the need for frequent hospital visits, and improving accessibility for individuals with chronic health concerns. For example, in June 2024, the National Health Service in the UK reported that 3,615,330 individuals were diagnosed with non-diabetic hyperglycemia, a condition indicating elevated blood sugar levels, in 2023, an 18% increase from 2022. This trend highlights the growing demand for continuous monitoring, driving the diagnostics-as-a-service market.

The increasing adoption of personalized medicine is also contributing to the growth of the diagnostics-as-a-service market. Personalized medicine tailors treatment and prevention plans based on an individual's genetic makeup, lifestyle, and environment. The rise of this approach is largely due to advancements in genomics, which allow for the precise identification of genetic variations and the creation of individualized treatments. Diagnostics-as-a-service enhances personalized medicine by offering cloud-based diagnostic tools that provide rapid, accurate patient assessments. These services streamline data collection and analysis, supporting customized treatment strategies and improving clinical decision-making. For instance, in February 2024, the Personalized Medicine Coalition reported that the U.S. Food and Drug Administration approved 26 new personalized medicines in 2023, a significant increase from the 12 approved in 2022. This surge in personalized medicine adoption is fueling the growth of the diagnostics-as-a-service market.

Companies in the diagnostics-as-a-service market are increasingly focusing on developing patient-centric solutions, such as at-home lab testing services, to improve convenience and accessibility. At-home lab testing services allow individuals to collect samples at home and receive test results without needing to visit a clinic. For example, in June 2025, Amazon India partnered with Orange Health Labs to launch Amazon Diagnostics, an at-home lab testing service under Amazon Medical. Available in six major cities, the service offers doorstep sample collection within 60 minutes and delivers digital reports in as little as six hours, covering over 800 diagnostic tests. Customers can book, track, and access secure test results through the Amazon app. This initiative addresses key challenges in India's diagnostic sector, such as delays, accessibility, and quality, while aligning with Amazon's broader goal of providing comprehensive healthcare services, including pharmacy and clinics.

Major players in the diagnostics-as-a-service market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare Technologies Inc., Becton Dickinson and Company, Agilent Technologies Inc., Hologic Inc., Bio-Rad Laboratories Inc., Guardant Health Inc., Invitae Corporation, InHealth Group Limited, Canon Medical Systems Corporation, Freenome Holdings Inc., BioSerenity SAS, PathAI Inc., Butterfly Network Inc., Aidoc Medical Ltd., Owkin Inc., K Health Inc., and Probatix GmbH.

North America was the largest region in the diagnostics-as-a-service market in 2024. The regions covered in diagnostics-as-a-service report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the diagnostics-as-a-service market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The diagnostics-as-a-service market includes revenues earned by entities through remote diagnostic testing, laboratory analysis, sample collection and processing, cloud-based reporting, and teleconsultation for test interpretation. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Diagnostics-As-A-Service Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on diagnostics-as-a-service market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for diagnostics-as-a-service ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The diagnostics-as-a-service market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Component: Software; Services; Platforms
• 2) By Deployment Mode: Cloud-Based; On-Premises; Hybrid
• 3) By Application: Clinical Diagnostics; Imaging Diagnostics; Pathology; Genomics; Other Applications
• 4) By End-User: Hospitals And Clinics; Diagnostic Laboratories; Research Institutes; Other End Users
• Subsegments:
• 1) By Software: Diagnostic Analytics Software; Clinical Decision Support Software; Artificial Intelligence (AI) Or Machine Learning (ML)-Based Diagnostic Tools; Imaging And Visualization Software; Data Integration And Interoperability Software; Remote Monitoring And Reporting Software
• 2) By Services: Diagnostic Testing Services; Remote And Virtual Diagnostic Services; Cloud-Based Data Storage And Management; Consulting And Implementation Services; Training And Support Services; Maintenance And Upgradation Services
• 3) By Platforms: Cloud-based Diagnostic Platforms; On-Premise Diagnostic Platforms; Hybrid Deployment Platforms; Application Programming Interface (API) And Integration Platforms; Mobile Or Tele-Diagnostics Platforms; Data Exchange And Collaboration Platforms
• Companies Mentioned: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Siemens Healthineers AG; Koninklijke Philips N.V.; GE Healthcare Technologies Inc.; Becton Dickinson and Company; Agilent Technologies Inc.; Hologic Inc.; Bio-Rad Laboratories Inc.; Guardant Health Inc.; Invitae Corporation; InHealth Group Limited; Canon Medical Systems Corporation; Freenome Holdings Inc.; BioSerenity SAS; PathAI Inc.; Butterfly Network Inc.; Aidoc Medical Ltd.; Owkin Inc.; K Health Inc.; Probatix GmbH
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Diagnostics-As-A-Service Market Characteristics

3. Diagnostics-As-A-Service Market Trends And Strategies

4. Diagnostics-As-A-Service Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Diagnostics-As-A-Service Growth Analysis And Strategic Analysis Framework

• 5.1. Global Diagnostics-As-A-Service PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Diagnostics-As-A-Service Market Growth Rate Analysis
• 5.4. Global Diagnostics-As-A-Service Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Diagnostics-As-A-Service Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Diagnostics-As-A-Service Total Addressable Market (TAM)

6. Diagnostics-As-A-Service Market Segmentation

• 6.1. Global Diagnostics-As-A-Service Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Software
• Services
• Platforms
• 6.2. Global Diagnostics-As-A-Service Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cloud-Based
• On-Premises
• Hybrid
• 6.3. Global Diagnostics-As-A-Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Clinical Diagnostics
• Imaging Diagnostics
• Pathology
• Genomics
• Other Applications
• 6.4. Global Diagnostics-As-A-Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Diagnostic Laboratories
• Research Institutes
• Other End Users
• 6.5. Global Diagnostics-As-A-Service Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostic Analytics Software
• Clinical Decision Support Software
• Artificial Intelligence (AI) Or Machine Learning (ML)-Based Diagnostic Tools
• Imaging And Visualization Software
• Data Integration And Interoperability Software
• Remote Monitoring And Reporting Software
• 6.6. Global Diagnostics-As-A-Service Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostic Testing Services
• Remote And Virtual Diagnostic Services
• Cloud-Based Data Storage And Management
• Consulting And Implementation Services
• Training And Support Services
• Maintenance And Upgradation Services
• 6.7. Global Diagnostics-As-A-Service Market, Sub-Segmentation Of Platforms, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cloud-Based Diagnostic Platforms
• On-premise Diagnostic Platforms
• Hybrid Deployment Platforms
• Application Programming Interface (API) And Integration Platforms
• Mobile Or Tele-diagnostics Platforms
• Data Exchange And Collaboration Platforms

7. Diagnostics-As-A-Service Market Regional And Country Analysis

• 7.1. Global Diagnostics-As-A-Service Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Diagnostics-As-A-Service Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Diagnostics-As-A-Service Market

• 8.1. Asia-Pacific Diagnostics-As-A-Service Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Diagnostics-As-A-Service Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Diagnostics-As-A-Service Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Diagnostics-As-A-Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Diagnostics-As-A-Service Market

• 9.1. China Diagnostics-As-A-Service Market Overview
• 9.2. China Diagnostics-As-A-Service Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Diagnostics-As-A-Service Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Diagnostics-As-A-Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Diagnostics-As-A-Service Market

• 10.1. India Diagnostics-As-A-Service Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Diagnostics-As-A-Service Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Diagnostics-As-A-Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Diagnostics-As-A-Service Market

• 11.1. Japan Diagnostics-As-A-Service Market Overview
• 11.2. Japan Diagnostics-As-A-Service Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Diagnostics-As-A-Service Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Diagnostics-As-A-Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Diagnostics-As-A-Service Market

• 12.1. Australia Diagnostics-As-A-Service Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Diagnostics-As-A-Service Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Diagnostics-As-A-Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Diagnostics-As-A-Service Market

• 13.1. Indonesia Diagnostics-As-A-Service Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Diagnostics-As-A-Service Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Diagnostics-As-A-Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Diagnostics-As-A-Service Market

• 14.1. South Korea Diagnostics-As-A-Service Market Overview
• 14.2. South Korea Diagnostics-As-A-Service Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Diagnostics-As-A-Service Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Diagnostics-As-A-Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Diagnostics-As-A-Service Market

• 15.1. Western Europe Diagnostics-As-A-Service Market Overview
• 15.2. Western Europe Diagnostics-As-A-Service Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Diagnostics-As-A-Service Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Diagnostics-As-A-Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Diagnostics-As-A-Service Market

• 16.1. UK Diagnostics-As-A-Service Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Diagnostics-As-A-Service Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Diagnostics-As-A-Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Diagnostics-As-A-Service Market

• 17.1. Germany Diagnostics-As-A-Service Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Diagnostics-As-A-Service Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Diagnostics-As-A-Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Diagnostics-As-A-Service Market

• 18.1. France Diagnostics-As-A-Service Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Diagnostics-As-A-Service Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Diagnostics-As-A-Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Diagnostics-As-A-Service Market

• 19.1. Italy Diagnostics-As-A-Service Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Diagnostics-As-A-Service Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Diagnostics-As-A-Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Diagnostics-As-A-Service Market

• 20.1. Spain Diagnostics-As-A-Service Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Diagnostics-As-A-Service Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Diagnostics-As-A-Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Diagnostics-As-A-Service Market

• 21.1. Eastern Europe Diagnostics-As-A-Service Market Overview
• 21.2. Eastern Europe Diagnostics-As-A-Service Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Diagnostics-As-A-Service Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Diagnostics-As-A-Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Diagnostics-As-A-Service Market

• 22.1. Russia Diagnostics-As-A-Service Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Diagnostics-As-A-Service Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Diagnostics-As-A-Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Diagnostics-As-A-Service Market

• 23.1. North America Diagnostics-As-A-Service Market Overview
• 23.2. North America Diagnostics-As-A-Service Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Diagnostics-As-A-Service Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Diagnostics-As-A-Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Diagnostics-As-A-Service Market

• 24.1. USA Diagnostics-As-A-Service Market Overview
• 24.2. USA Diagnostics-As-A-Service Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Diagnostics-As-A-Service Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Diagnostics-As-A-Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Diagnostics-As-A-Service Market

• 25.1. Canada Diagnostics-As-A-Service Market Overview
• 25.2. Canada Diagnostics-As-A-Service Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Diagnostics-As-A-Service Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Diagnostics-As-A-Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Diagnostics-As-A-Service Market

• 26.1. South America Diagnostics-As-A-Service Market Overview
• 26.2. South America Diagnostics-As-A-Service Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Diagnostics-As-A-Service Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Diagnostics-As-A-Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Diagnostics-As-A-Service Market

• 27.1. Brazil Diagnostics-As-A-Service Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Diagnostics-As-A-Service Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Diagnostics-As-A-Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Diagnostics-As-A-Service Market

• 28.1. Middle East Diagnostics-As-A-Service Market Overview
• 28.2. Middle East Diagnostics-As-A-Service Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Diagnostics-As-A-Service Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Diagnostics-As-A-Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Diagnostics-As-A-Service Market

• 29.1. Africa Diagnostics-As-A-Service Market Overview
• 29.2. Africa Diagnostics-As-A-Service Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Diagnostics-As-A-Service Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Diagnostics-As-A-Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Diagnostics-As-A-Service Market Competitive Landscape And Company Profiles

• 30.1. Diagnostics-As-A-Service Market Competitive Landscape
• 30.2. Diagnostics-As-A-Service Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis

31. Diagnostics-As-A-Service Market Other Major And Innovative Companies

• 31.1. GE Healthcare Technologies Inc.
• 31.2. Becton Dickinson and Company
• 31.3. Agilent Technologies Inc.
• 31.4. Hologic Inc.
• 31.5. Bio-Rad Laboratories Inc.
• 31.6. Guardant Health Inc.
• 31.7. Invitae Corporation
• 31.8. InHealth Group Limited
• 31.9. Canon Medical Systems Corporation
• 31.10. Freenome Holdings Inc.
• 31.11. BioSerenity SAS
• 31.12. PathAI Inc.
• 31.13. Butterfly Network Inc.
• 31.14. Aidoc Medical Ltd.
• 31.15. Owkin Inc.

32. Global Diagnostics-As-A-Service Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Diagnostics-As-A-Service Market

34. Recent Developments In The Diagnostics-As-A-Service Market

35. Diagnostics-As-A-Service Market High Potential Countries, Segments and Strategies

• 35.1 Diagnostics-As-A-Service Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Diagnostics-As-A-Service Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Diagnostics-As-A-Service Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer